Cooper Cash Flow from Financial Activities 2012-2026 | COO
Cooper annual/quarterly cash flow from financial activities history and growth rate from 2012 to 2026. Cash flow from financial activities can be defined as the net amount of cash transactions used in funding activities
- Cooper cash flow from financial activities for the quarter ending April 30, 2026 was $-0.426B, a 1186.48% decline year-over-year.
- Cooper cash flow from financial activities for the twelve months ending April 30, 2026 was $-0.889B, a 287.48% decline year-over-year.
- Cooper annual cash flow from financial activities for 2025 was $-0.426B, a 1186.48% decline from 2024.
- Cooper annual cash flow from financial activities for 2024 was $0.039B, a 122.54% decline from 2023.
- Cooper annual cash flow from financial activities for 2023 was $-0.174B, a 114.57% decline from 2022.
|
Cooper Annual Cash Flow Financial (Millions of US $) |
|
|---|---|
| 2025 | $-426 |
| 2024 | $39 |
| 2023 | $-174 |
| 2022 | $1,194 |
| 2021 | $-311 |
| 2020 | $-96 |
| 2019 | $-351 |
| 2018 | $844 |
| 2017 | $-228 |
| 2016 | $-1 |
| 2015 | $-107 |
| 2014 | $842 |
| 2013 | $-162 |
| 2012 | $-68 |
| 2011 | $-173 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $13.894B | $4.092B |
| The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |